Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Maternal SSRIs experience and risk of ASD in offspring: a review
Zainab Fatima1, Aqeela Zahra2,3, Maria Ghouse2
1National Reference Laboratory of Veterinary Drug Residues and MAO Key Laboratory for Detection of Veterinary Drug Residues , Huazhong Agricultural University (HZAU) , Wuhan , China . Email: wangxu@mail.hzau.edu.cn ; Email: yuan5802@mail.hzau.edu.cn ; ; Fax: +86-27-87672232 ; Tel: +86-27-87287186 ; Tel: +86-27-87287186.
Insights
Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) during pregnancy may be linked to an increased risk of autism spectrum disorders (ASDs) in children. Further research is needed to confirm this association.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Psychiatry
Background:
- Antidepressants are commonly prescribed during pregnancy.
- Prenatal exposure to antidepressants is linked to adverse outcomes like malformations and low birth weight.
- Emerging evidence suggests potential impacts on child neurodevelopment.
Purpose of the Study:
- To review the existing literature on the association between prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and the risk of autism spectrum disorders (ASDs).
Main Methods:
- A systematic review and compilation of twelve studies investigating the link between gestational SSRI exposure and ASD in children.
- Exploration of the current knowledge gap regarding this specific association.
Main Results:
- The available data indicate a potential signal suggesting that antenatal SSRI exposure may elevate the risk of ASDs.
- Despite limitations in current research, a preliminary association is observed.
Conclusions:
- A potential association exists between prenatal SSRI use and an increased risk of ASDs in children.
- There is a critical need for larger, well-designed studies to conclusively determine the risk and its magnitude.
Abstract:
Antidepressants are extensively used during pregnancy and associated with severe outcomes, including innate malformations, prematurity, and low birth weight, etc. A recent study suggested that prenatal exposure to antidepressants may impair child neurodevelopment process. Thus, the aim of this review is to investigate the potential association between prenatal use of selective 5-HT reuptake inhibitors (SSRIs) and the risk of autism spectrum disorders (ASDs). Twelve studies related to the linkage between SSRI exposure during pregnancy and ASD in children were explored and compiled. However, there is a knowledge gap concerning the potential link between gestational exposure to antidepressants and the risk of ASDs. Despite such limitations, the available data show that some signal exists and signifies that antenatal exposure to SSRIs may increase the risk of ASDs. Thus, there is a vital need for further, large and well-designed research to definitively evaluate the existence and the magnitude of this severe risk.
More Related Videos
08:42A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Relative Risk
What is an Experiment?
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...